tiprankstipranks
Trending News
More News >
Xeris Pharmaceuticals (XERS)
NASDAQ:XERS
US Market

Xeris Pharmaceuticals (XERS) Ratios

Compare
1,095 Followers

Xeris Pharmaceuticals Ratios

XERS's free cash flow for Q4 2025 was $0.78. For the 2025 fiscal year, XERS's free cash flow was decreased by $ and operating cash flow was $0.13. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
2.19 2.19 1.67 1.64 2.54
Quick Ratio
1.57 1.57 1.19 1.23 2.20
Cash Ratio
1.01 1.01 0.71 0.71 1.66
Solvency Ratio
0.04 0.03 -0.12 -0.15 -0.27
Operating Cash Flow Ratio
0.26 0.26 -0.37 -0.49 -1.40
Short-Term Operating Cash Flow Coverage
4.59 4.59 -2.45 0.00 0.00
Net Current Asset Value
$ -129.53M$ -129.53M$ -185.01M$ -173.12M$ -112.52M
Leverage Ratios
Debt-to-Assets Ratio
0.10 0.10 0.84 0.71 0.57
Debt-to-Equity Ratio
2.76 2.76 -9.17 -33.79 4.38
Debt-to-Capital Ratio
0.73 0.73 1.12 1.03 0.81
Long-Term Debt-to-Capital Ratio
0.70 0.70 1.16 1.04 0.81
Financial Leverage Ratio
28.02 28.02 -10.91 -47.57 7.62
Debt Service Coverage Ratio
0.99 0.36 -0.24 -0.85 -4.81
Interest Coverage Ratio
0.86 0.86 -1.01 -1.65 -5.81
Debt to Market Cap
0.04 0.03 0.47 0.59 1.04
Interest Debt Per Share
0.40 0.42 2.08 1.86 1.56
Net Debt to EBITDA
-2.09 -5.77 -14.28 -6.81 -1.10
Profitability Margins
Gross Profit Margin
81.70%81.70%81.86%82.52%79.47%
EBIT Margin
7.70%0.19%-13.11%-22.51%-74.36%
EBITDA Margin
12.00%4.36%-6.89%-14.48%-62.87%
Operating Profit Margin
8.53%8.53%-16.57%-26.85%-74.32%
Pretax Profit Margin
0.19%0.19%-28.12%-38.74%-87.15%
Net Profit Margin
0.19%0.19%-27.00%-37.98%-85.86%
Continuous Operations Profit Margin
0.19%0.19%-27.00%-37.98%-85.86%
Net Income Per EBT
100.00%100.00%96.03%98.03%98.52%
EBT Per EBIT
2.23%2.23%169.72%144.29%117.26%
Return on Assets (ROA)
0.14%0.14%-16.97%-19.30%-27.48%
Return on Equity (ROE)
-5.33%4.05%185.16%917.94%-209.49%
Return on Capital Employed (ROCE)
9.09%9.09%-15.11%-19.35%-30.25%
Return on Invested Capital (ROIC)
8.89%8.89%-13.25%-18.68%-29.63%
Return on Tangible Assets
0.20%0.20%-27.24%-32.77%-47.08%
Earnings Yield
0.06%0.04%-11.02%-19.24%-52.48%
Efficiency Ratios
Receivables Turnover
5.72 5.72 5.02 4.18 3.58
Payables Turnover
17.36 17.36 16.08 2.48 4.91
Inventory Turnover
0.78 0.78 0.76 0.74 0.92
Fixed Asset Turnover
10.79 10.79 7.20 5.62 11.60
Asset Turnover
0.76 0.76 0.63 0.51 0.32
Working Capital Turnover Ratio
2.45 2.95 3.17 1.88 1.25
Cash Conversion Cycle
512.11 512.11 527.36 434.80 426.67
Days of Sales Outstanding
63.85 63.85 72.64 87.28 102.07
Days of Inventory Outstanding
469.29 469.29 477.41 494.88 398.88
Days of Payables Outstanding
21.02 21.02 22.69 147.36 74.28
Operating Cycle
533.14 533.14 550.05 582.16 500.95
Cash Flow Ratios
Operating Cash Flow Per Share
0.17 0.18 -0.25 -0.34 -0.76
Free Cash Flow Per Share
0.23 0.17 -0.26 -0.36 -0.76
CapEx Per Share
<0.01 <0.01 <0.01 0.02 <0.01
Free Cash Flow to Operating Cash Flow
1.32 0.98 1.02 1.05 1.01
Dividend Paid and CapEx Coverage Ratio
41.13 41.13 -42.60 -20.78 -196.36
Capital Expenditure Coverage Ratio
41.13 41.13 -42.60 -20.78 -196.36
Operating Cash Flow Coverage Ratio
0.76 0.76 -0.14 -0.21 -0.52
Operating Cash Flow to Sales Ratio
0.10 0.10 -0.18 -0.29 -0.93
Free Cash Flow Yield
3.91%2.22%-7.61%-15.23%-57.33%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
1.68K 2.27K -9.07 -5.20 -1.91
Price-to-Sales (P/S) Ratio
3.31 4.32 2.45 1.97 1.64
Price-to-Book (P/B) Ratio
68.01 92.00 -16.80 -47.71 3.99
Price-to-Free Cash Flow (P/FCF) Ratio
25.61 45.09 -13.15 -6.56 -1.74
Price-to-Operating Cash Flow Ratio
32.52 43.99 -13.45 -6.88 -1.75
Price-to-Earnings Growth (PEG) Ratio
17.29 -22.52 0.51 0.15 0.03
Price-to-Fair Value
68.01 92.00 -16.80 -47.71 3.99
Enterprise Value Multiple
25.52 93.32 -49.83 -20.45 -3.70
Enterprise Value
894.06M 1.19B 697.39M 485.28M 256.48M
EV to EBITDA
25.52 93.32 -49.83 -20.45 -3.70
EV to Sales
3.06 4.06 3.43 2.96 2.33
EV to Free Cash Flow
23.67 42.47 -18.43 -9.85 -2.48
EV to Operating Cash Flow
31.23 41.43 -18.86 -10.32 -2.49
Tangible Book Value Per Share
-0.59 -0.61 -1.03 -1.01 -0.72
Shareholders’ Equity Per Share
0.08 0.09 -0.20 -0.05 0.33
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.04 0.02 0.01
Revenue Per Share
1.76 1.82 1.38 1.19 0.81
Net Income Per Share
<0.01 <0.01 -0.37 -0.45 -0.70
Tax Burden
1.00 1.00 0.96 0.98 0.99
Interest Burden
0.02 1.00 2.15 1.72 1.17
Research & Development to Revenue
0.11 0.11 0.13 0.14 0.19
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.08 0.08 0.09 0.07 0.11
Income Quality
51.67 51.67 0.67 0.76 1.09
Currency in USD